Tumour-targeted chemotherapy with immunoconjugates of calicheamicin

Author： Damle Nitin K  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.4, Iss.9, 2004-09, pp. : 1445-1452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Designing immunoconjugates for cancer therapy

By Govindan Serengulam V   Goldenberg David M  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 873-890

Informa Healthcare

Access to resources Recommend Favorite

Mitochondria-targeted antioxidants do not prevent tumour necrosis factor-induced necrosis of L929 cells

By Jarvis Reagan M.   Göttert Jana   Murphy Michael P.   Ledgerwood Elizabeth C.  

Free Radical Research, Vol. 41, Iss. 9, 2007-01 ,pp. : 1041-1046

Informa Healthcare

Access to resources Recommend Favorite

Eukaryotic expression vectors and immunoconjugates for cancer therapy

By Glinka E.   Edelweiss E.   Deyev S.  

Biochemistry (Moscow), Vol. 71, Iss. 6, 2006-06 ,pp. : 597-606

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Solution Structure of the Calicheamicin &ggr;1I-DNA Complex

By Kumar R.A.   Ikemoto N.   Patel D.J.  

Journal of Molecular Biology, Vol. 265, Iss. 2, 1997-01 ,pp. : 187-201

Academic Press

Access to resources Recommend Favorite

Using antibodies in tumour immunotherapy

By Schultes Birgit C   Nicodemus Christopher F  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1265-1284

Informa Healthcare

Access to resources Recommend Favorite